Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues

Shokoples, Brandon G.; Paradis, Pierre; Schiffrin, Ernesto L.

doi:10.1038/s41440-024-01731-6

Hypertens Res

2024

DOI: 10.1038/s41440-024-01731-6

|View full text |Cite

Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues

Brandon G. Shokoples,

Pierre Paradis,

Ernesto L. Schiffrin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 69 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Purinergic Receptor Antagonists: A Complementary Treatment for Hypertension

Bautista-Pérez,

Franco

2024

Pharmaceuticals

View full text Add to dashboard Cite

The treatment of hypertension has improved in the last century; attention has been directed to restoring several altered pathophysiological mechanisms. However, regardless of the current treatments, it is difficult to control blood pressure. Uncontrolled hypertension is responsible for several cardiovascular complications, such as chronic renal failure, which is frequently observed in hypertensive patients. Therefore, new approaches that may improve the control of arterial blood pressure should be considered to prevent serious cardiovascular disorders. The contribution of purinergic receptors has been acknowledged in the pathophysiology of hypertension; this review describes the participation of these receptors in the alteration of kidney function in hypertension. Elevated interstitial ATP concentrations are essential for the activation of renal purinergic receptors; this becomes a fundamental pathway that leads to the development and maintenance of hypertension. High ATP levels modify essential mechanisms implicated in the long-term control of blood pressure, such as pressure natriuresis, the autoregulation of the glomerular filtration rate and renal blood flow, and tubuloglomerular feedback responses. Any alteration in these mechanisms decreases sodium excretion. ATP stimulates the release of vasoactive substances, causes renal function to decline, and induces tubulointerstitial damage. At the same time, a deleterious interaction involving angiotensin II and purinergic receptors leads to the deterioration of renal function.

show abstract

Purinergic Receptor Antagonists: A Complementary Treatment for Hypertension

Bautista-Pérez,

Franco

2024

Pharmaceuticals

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues

Cited by 1 publication

References 69 publications

Purinergic Receptor Antagonists: A Complementary Treatment for Hypertension

Purinergic Receptor Antagonists: A Complementary Treatment for Hypertension

Contact Info

Product

Resources

About